CNBC February 14, 2024
Annika Kim Constantino

Key Points

– The Federal Trade Commission said it is examining the role drug wholesalers and companies that purchase medicines for U.S. health-care providers play in shortages of generic drugs.

– The move follows an unprecedented shortfall of crucial medicine over the last year, which has forced hospitals to ration drugs ranging from injectable cancer therapies to pain treatments.

– In a joint request for information, the FTC and the Department of Health and Human Services are seeking public comment on the contracting practices, market concentration, and compensation of two types of middlemen: group purchasing organizations and drug wholesalers.

The Federal Trade Commission on Wednesday said it is examining the role that drug wholesalers and companies that purchase medicines for...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Supply Chain, Technology
Preserving Biological Order: Why Supply Chain Disruptions Are Patient Safety Crises
Why supply chain ROI is shifting from price to prevention
Healthcare Trend Report: A Review of the Pharmacy and Drug Supply Chain Sectors
HHS outlines plan to bolster the US medical supply chain and 3 more updates to know
Seven steps to AI supply chain visibility — before a breach forces the issue

Share Article